Results 101 to 110 of about 120,903,364 (211)
Immunosuppression, tonsillectomy and remissions in high-risk IgA-nephropathy
Aim.To evaluate the efficacy of immunosuppressive therapy (IST) and tonsillectomy (TE) in patients with high-risk IgA nephropathy (IgAN). Materials and мethods.
Zinaida Sh. Kochoyan +3 more
doaj +1 more source
Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley +1 more source
Clinicopathological Profile of Immunoglobulin A Nephropathy Patients
Background Immunoglobulin A nephropathy (IgAN) is the most prevalent glomerulonephritis (GN) in the world. It has variation in presentation among the patients.
Deepak Sharma +3 more
doaj +1 more source
This graphical abstract summarizes the association between the neutrophil percentage‐to‐albumin ratio (NPAR), renal pathology, and prognosis in biopsy‐confirmed diabetic kidney disease. Higher NPAR was associated with increased renal MPO‐positive neutrophil infiltration, more severe histopathological injury, and poorer renal outcomes.
Yang Li +9 more
wiley +1 more source
Background: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and an important cause of chronic kidney disease and kidney failure.
Douaa Yasss Khudair, +1 more
doaj +1 more source
Background: The efficacy and safety of telmisartan combined with clopidogrel, leflunomide, or both drugs for immunoglobulin A nephropathy (IgAN) are unclear.
Jie Wu +18 more
doaj +1 more source
Immunoglobulin A nephropathy [PDF]
J V, Donadio, J P, Grande
openaire +2 more sources
Immunoglobulin A (IgA) nephropathy is a very common primary glomerular disease that could lead to kidney failure. In patients with IgA nephropathy, the effect of corticosteroids remains controversial on clinical outcomes.
Xiangxue Lu
core +1 more source
The role of metformin and its downstream targets in IgA nephropathy (IgAN) remains unclear. In this study, we used Mendelian randomization to explore potential causal links between genetic proxies of metformin targets, plasma proteins, and the risk of ...
Yan Zhang +4 more
doaj +1 more source
Cancer in IgA nephropathy; a letter to the editor on current findings [PDF]
Maryam ALem +5 more
doaj +1 more source

